Opthea Expands Leadership Team with the Appointment of Joel Naor, M.D., M.Sc., MBA as Chief ...
Key appointment as Opthea progresses the Phase 3 clinical development of OPT-302 in wet AMD
Source: kulr8.com
Stay updated with breaking news from Stem Cells Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key appointment as Opthea progresses the Phase 3 clinical development of OPT-302 in wet AMD